TimesSquare Capital Management, LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1313816 NEW YORK, NY

Position in KRYS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$41,457,930

+$12,437,745 QoQ

Shares Held

111,545

-0.7% QoQ

Ownership

0.377%

of shares outstanding

% of Portfolio

0.62%

of 13F equity value

Holder Rank

#36

of 419 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Jun 30, 2026

TimesSquare Capital Management, LLC holds $522,649,738 across 18 Biotechnology names. KRYS ranks #5 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	728,096	$77,629,595
2	ARGX	Argenx SE	83,114	$77,110,675
3	IONS	Ionis Pharmaceuticals Inc	614,070	$48,689,610
4	MIRM	Mirum Pharmaceuticals, Inc.	367,281	$42,997,586
5	KRYS	Krystal Biotech, Inc. This page	111,545	$41,457,930
6	XENE	Xenon Pharmaceuticals Inc.	451,593	$27,258,153
7	NAMS	NewAmsterdam Pharma Co N.V.	796,162	$26,981,930
8	VCEL	Vericel Corp	549,846	$24,462,648

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$41,457,930	111,545	-0.7%	Shares	Sole	2026-08-07
2026-03-31	$29,020,185	112,342	+15.3%	Shares	Sole	2026-05-07
2025-12-31	$24,012,996	97,400	-17.8%	Shares	Sole	2026-02-06
2025-09-30	$20,921,276	118,514	+3.8%	Shares	Sole	2025-11-07
2025-06-30	$15,698,481	114,204	-19.7%	Shares	Sole	2025-08-08
2025-03-31	$25,635,594	142,183	-10.5%	Shares	Sole	2025-05-02
2024-12-31	$24,888,260	158,868	+39.1%	Shares	Sole	2025-02-03
2024-09-30	$20,791,830	114,222	+37.6%	Shares	Sole	2024-11-04
2024-06-30	$15,249,281	83,039	-14.5%	Shares	Sole	2024-08-08
2024-03-31	$17,287,856	97,161	-61.2%	Shares	Sole	2024-05-07
2023-12-31	$31,073,308	250,470	+103.6%	Shares	Sole	2024-02-07
2023-09-30	$14,272,060	123,035	—	Shares	Sole	2023-11-17
No filing history on record for this holder in this stock.